Enhancement of basic fibroblast growth factor-stimulated VEGF synthesis by Wnt3a in osteoblasts

International Journal of Molecular Medicine

Volumn 27, Issue 6, 2011, Pages 859-864

  Tokuda, Haruhiko ^a,b   Adachi, Seiji ^b   Matsushima Nishiwaki, Rie ^b   Kato, Kenji ^b,c   Natsume, Hideo ^b,c   Otsuka, Takanobu ^c   Kozawa, Osamu ^b  

^a NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

^b GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

catenin; Fibroblast growth factor; Osteoblast; Vascular endothelial growth factor; Wnt

Indexed keywords

2 (2,4 DICHLOROPHENYL) 3 (1 METHYL 3 INDOLYL)MALEIMIDE; BASIC FIBROBLAST GROWTH FACTOR; BETA CATENIN; GLYCOGEN SYNTHASE KINASE 3BETA; LITHIUM CHLORIDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE B; S6 KINASE; STRESS ACTIVATED PROTEIN KINASE; VASCULOTROPIN; WNT3A PROTEIN;

ANIMAL CELL; ARTICLE; BONE MASS; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; GENE EXPRESSION; MOUSE; NEWBORN; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; CELLS, CULTURED; FIBROBLAST GROWTH FACTOR 2; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; OSTEOBLASTS; PHOSPHORYLATION; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WNT PROTEINS;

EID: 79954526437     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2011.644     Document Type: Article

References (31)

1. Ferrara N: Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 25: 581-611, 2004.
2. Karsenty G and Wagner EF: Reaching a genetic and molecular understanding of skeletal development. Dev Cell 2: 389-406, 2002.
3. Erlebacher A, Filvaroff EH, Gitelman SE and Derynck R: Toward a molecular understanding of skeletal development. Cell 80: 371-378, 1995.
4. Zelzer E and Olsen BR: Multiple roles of vascular endothelial growth factor (VEGF) in skeletal development, growth, and repair. Curr Top Dev Biol 65: 169-187, 2005.
5. Baylink DJ, Finkleman RD and Mohan S: Growth factor to stimulate bone formation. J Bone Miner Res 8: S565-S572, 1993.
6. Bolander ME: Regulation of fracture repair by growth factors stimulate tyrosine kinase activity in vivo. Proc Soc Exp Biol Med 200: 165-170, 1992.
7. Marie PJ: Fibroblast growth factor signaling controlling osteoblast differentiation. Gene 316: 23-32, 2003.
8. Saadeh PB, Mehrara BJ, Steinbrech DS, Spector JA, Greenwald JA, Chin GS, Ueno H, Gittes GK and Longaker MT: Mechanisms of fibroblast growth factor-2 modulation of vascular endothelial growth factor expression by osteoblastic cells. Endocrinology 141: 2075-2083, 2000.
9. Tokuda H, Kozawa O and Uematsu T: Basic fibroblast growth factor stimulates vascular endothelial growth factor release in osteoblasts: divergent regulation by p44/p42 mitogen-activated protein kinase and p38 mitogen-activated protein kinase. J Bone Miner Res 15: 2371-2379, 2000.
10. Tokuda H, Hirade K, Wang X, Oiso Y and Kozawa O: Involvement of SAPK/JNK in basic fibroblast growth factor-induced VEGF release in osteoblasts. J Endocrinol 177: 101-107, 2003.
11. Kyriakis JM and Avruch J: Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 81: 807-869, 2001.
12. Moon RT, Bowerman B, Boutros M and Perrimon N: The promise and perils of Wnt signaling through β-catenin. Science 296: 1644-1646, 2002.
13. van Amerongen R and Nusse R: Towards an integrated view of Wnt signaling in development. Development 136: 3205-3214, 2009.
14. Milat F and Wah Ng K: Is Wnt signaling the final common pathway leading to bone formation? Mol Cel Endocrinol 310: 52-62, 2009.
15. Hu H, Hilton MJ, Tu X, Yu K, Omitz DM and Long F: Sequential roles of Hedgehog and Wnt signaling in osteoblast development. Development 132: 49-60, 2005.
16. Krishnan V, Bryant HU and Macdougald OA: Regulation of bone mass by Wnt signaling. J Clin Invest 116: 1202-1209, 2006.
17. Rodda SJ and McMahon AP: Distinct roles for hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors. Development 133: 3231-3244, 2006.
18. Almeida M, Han L, Bellido T, Manolagas SC and Kousteni S: Wnt proteins prevent apoptosis of both uncommitted osteoblast progenitors and differentiated osteoblasts by β-catenin-dependent and -independent signaling cascades involving Src/ERK and phosphatidylinositol 3-kinase/AKT. J Biol Chem 280: 41342-41351, 2005.
19. Sudo H, Kodama H, Amagai Y, Yamamoto S and Kasai S: In vitro differentiation and calci fication in a new clonal osteogenic cell line derived from newborn mouse calvaria. J Cell Biol 96: 191-198, 1983.
20. Kozawa O, Tokuda H, Miwa M, Kotoyori J and Oiso Y: Cross-talk regulation between cyclic AMP production and phosphoinositide hydrolysis induced by prostaglandin E2 in osteoblast-like cells. Exp Cell Res 198: 130-134, 1992.
21. Simpson DA, Feeney S, Boyle C and Stitt AW: Retinal VEGF mRNA measured by SYBR green I fluorescence: A versatile approach to quantitative PCR. Mol Vis 6: 178-183, 2000.
22. Kato K, Ito H, Hasegawa K, Inaguma Y, Kozawa O and Asano T: Modulation of the stress-induced synthesis of hsp27 and alpha B-crystallin by cyclic AMP in C6 rat glioma cells. J Neurochem 66: 946-950, 1996.
23. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
24. Stambolic V, Ruel L and Woodgett JR: Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signaling in intact cells. Curr Biol 6: 1664-1668, 1996.
25. Case N, Ma M, Sen B, Xie Z, Gross TS and Rubin J: β-catenin levels influence rapid mechanical responses in osteoblasts. J Biol Chem 283: 29196-29205, 2008.
26. Carmichael J, Sugars KL, Bao YP and Rubinsztein DC: Glycogen synthase kinase-3β inhibitors prevent cellular polyglutamine toxicity caused by the Huntington's disease mutation. J Biol Chem 277: 33791-33798, 2002.
27. Takai S, Tokuda H, Hanai Y, Harada A, Yasuda E, Matsushima-Nishiwaki R, Kato H, Ogura S, Ohta T and Kozawa O: Negative regulation by p70 S6 kinase of FGF-2-induced VEGF release through stress-activated protein kinase/c-Jun N-terminal kinase in osteoblasts. J Bone Miner Res 22: 337-346, 2007.
28. Takai S, Tokuda H, Hanai Y and Kozawa O: Activation of phosphatidylinositol 3-kinase/Akt limits FGF-2-induced VEGF release in osteoblasts. Mol Cell Endocrinol 267: 46-54, 2007.
29. Chung YS, Baylink DJ, Srivastava AK, Amaar Y, Tapia B, Kasukawa Y and Mohan S: Effects of secreted frizzled-related protein3 on osteoblasts invitro. J Bone Miner Res 19: 1395-1402, 2004.
30. Gerber HP, Vu TH, Ryan AM, Kowalski J, Werb Z and Ferrara N: VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nature Med 5: 623-628, 1999.
31. Secreto FJ, Hoeppner LH and Westendorf JJ: Wnt signaling during fracture repair. Curr Osteoporos Res 7: 64-69, 2009.